|
US7216529B2
|
|
Method for controlling the integrity of a nanofiltration or reverse osmosis module, or module system
|
|
IL95681D0
|
|
Substituted benzoic acid esters and their preparation
|
|
EP0297191A1
|
|
Use of N-[(1-ethyl-2-pyrrolidinyl)methyl]-methoxy-5-sulfamoyl benzamide in the treatment of sterility
|
|
JO1455B1
|
|
process for the synthsis of novel benzodioxepanne and uses thereof in theraputics
|
|
RO95817B1
|
|
Process for preparing benzamide derivatives
|
|
IL95681A
|
|
Substituted alkyl 4-(4,5-dihydro-2-(imidazolyl,oxazolyl or thiazolyl)amino)benzoates and their preparation
|
|
RO95239B1
|
|
Process for preparing the n-(1-cyclohexanyl-methyl-2-pyrrolidinylmethyl)-8-ethyl- sulphonyl-1,5-benzodioxepan-6-carboxamide
|
|
IE862160L
|
|
Benzodioxepane derivative
|
|
RO95032B1
|
|
Process for preparing benzamide derivatives
|
|
FI861130A
|
|
2-methoxy-4-amino-5-alkylthio (or alkylsulfonyl) benzoic acid derivative.
|
|
FR2593504A1
|
|
Novel dihydrobenzofuranne - and chromane - carboxamide derivatives, processes for their preparation and their use as neuroleptics
|
|
FR2592042A1
|
|
Novel ortho-anisamides, process for obtaining them, and therapeutic applications
|
|
ES8706611A1
|
|
Percutaneous anaesthetic compsn. for topical application
|
|
AU4815985A
|
|
Synergistic contraceptive
|
|
IE852202L
|
|
Percutaneous anaesthetic composition
|
|
FR2586018A1
|
|
Novel benzodioxepanne, its synthesis process and therapeutic applications
|
|
FR2584605A1
|
|
Application of n- (1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide in the treatment of parkinson's disease
|
|
FR2584401A1
|
|
Novel benzamide, method for preparing the same, and application thereof in the therapeutic field
|
|
JPS6144886A
|
|
N-(2'-tetrahydrofuranyl)alkylbenzoic acid amide and manufacture
|
|
JPS6144854A
|
|
N-dichloroalkylbenzoic acid amide and manufacture
|
